Division of Hematologic Malignancies

Division head Marcel van den Brink collaborates with medical oncologist Robert Jenq on research into the role of bacteria in preventing graft-versus-host disease.
A Leader in Bone Marrow Transplant Research

Division head Marcel van den Brink collaborates with medical oncologist Robert Jenq on research into the role of bacteria in preventing graft-versus-host disease.

The Division of Hematologic Malignancies within Memorial Sloan Kettering’s Department of Medicine is dedicated to treating patients with a variety of blood cancers as well as some benign hematologic diseases. Our physicians and scientists are central players in advancing translational and clinical research and establishing the standard of care for patients with hematologic cancers.

Now Available: 2017 Annual Report

Learn More Arrow rightAn icon showing an arrow pointing to the right.